Results 1 to 10 of about 1,074,013 (250)

Acute Respiratory Distress [PDF]

Clinical Practice and Cases in Emergency Medicine, 2018
James Maloy, Nicholas Harrison, Amit Bahl   +2 more
doaj   +5 more sources

Woman in respiratory distress [PDF]

Journal of the American College of Emergency Physicians Open, 2021
Eric Frantz, Nima Sarani, Andrew Pirotte, Bradley S. Jackson   +3 more
doaj   +3 more sources

Intrapartum Respiratory Distress

Journal of Medical Ultrasound, 2017
S.W. Steven Shaw
doaj   +6 more sources

Association between body composition, sarcopenia and pulmonary function in chronic obstructive pulmonary disease

BMC Pulmonary Medicine, 2022
Background Chronic Obstructive Pulmonary Disease (COPD) is characterized by progressive and irreversible airflow limitation. Different factors that modify pulmonary function include age, sex, muscular strength, and a history of exposure to toxic agents ...
Nathalie Martínez-Luna, Arturo Orea-Tejeda, Dulce González-Islas, Laura Flores-Cisneros, Candace Keirns-Davis, Rocío Sánchez-Santillán, Ilse Pérez-García, Yael Gastelum-Ayala, Valeria Martínez-Vázquez, Óscar Martínez-Reyna   +9 more
doaj   +1 more source

The impact of hydration status and fluid distribution on pulmonary function in COPD patients

Scientific Reports, 2022
Chronic Obstructive Pulmonary Disease (COPD) patients have alterations in body composition. Bioelectrical impedance analysis (BIA) evaluates body composition, hydration status, and fluid distribution.
Arturo Orea-Tejeda, Manuel Gómez-Martínez, Dulce González-Islas, Laura Flores-Cisneros, Candace Keirns-Davis, Rocío Sánchez-Santillán, Ilse Pérez-García, Nathalie Martínez-Luna, Robinson Robles-Hernández, Carlos Sánchez-Moreno, Juan José Orozco-Gutíerrez   +10 more
doaj   +1 more source

Body composition and risk factors associated with sarcopenia in post-COVID patients after moderate or severe COVID-19 infections

BMC Pulmonary Medicine, 2022
Background Post-COVID-19 syndrome is characterized by diverse symptoms and abnormalities that persist beyond 12 weeks from the onset of acute COVID-19.
Dulce González-Islas, Carlos Sánchez-Moreno, Arturo Orea-Tejeda, Samantha Hernández-López, Fernanda Salgado-Fernández, Candace Keirns-Davis, Susana Galicia-Amor, Esperanza Trejo-Mellado, Laura Gochicoa-Rangel, Armando Castorena-Maldonado   +9 more
doaj   +1 more source

Impact of Clinician Recognition of Acute Respiratory Distress Syndrome on Evidenced-Based Interventions in the Medical ICU

Critical Care Explorations, 2021
OBJECTIVES:. Acute respiratory distress syndrome is underrecognized in the ICU, but it remains uncertain if acute respiratory distress syndrome recognition affects evidence-based acute respiratory distress syndrome care in the modern era.
V. Eric Kerchberger, MD, Ryan M. Brown, MD, Matthew W. Semler, MD, MSc, Zhiguo Zhao, MS, Tatsuki Koyama, PhD, David R. Janz, MD, Msc, Julie A. Bastarache, MD, Lorraine B. Ware, MD   +7 more
doaj   +1 more source

Correlation of Respiratory Physiologic Parameters in Mechanically Ventilated Coronavirus Disease 2019 Patients

Critical Care Explorations, 2021
Acute respiratory distress syndrome secondary to severe acute respiratory syndrome coronavirus-2 pneumonia or coronavirus disease 2019-related acute respiratory distress syndrome is the primary cause of mortality in coronavirus disease 2019. Some studies
Biplab K. Saha, MD, Sana Ghalib, MD, Hau Chieng, MD, Chad Pezzano, RT, Darren Lydon, RT, Paul Feustel, PhD, Thomas C. Smith, MD, Amit Chopra, MD   +7 more
doaj   +1 more source

Association between muscle quality index and pulmonary function in post-COVID-19 subjects

BMC Pulmonary Medicine, 2023
Background The SARS-CoV2 pandemic impacted many critically ill patients, causing sequelae, affecting lung function, and involving the musculoskeletal system. We evaluated the association between lung function and muscle quality index in severely ill post-
Dulce González-Islas, Robinson Robles-Hernández, Laura Flores-Cisneros, Arturo Orea-Tejeda, Susana Galicia-Amor, Nadia Hernández-López, Mariana I. Valdés-Moreno, Rocío Sánchez-Santillán, Juan Carlos García-Hernández, Armando Castorena-Maldonado   +9 more
doaj   +1 more source

Ribavirin aerosol in hospitalized adults with respiratory distress and COVID‐19: An open‐label trial

Clinical and Translational Science, 2023
There is an unmet medical need for effective treatments for hospitalized patients with coronavirus disease 2019 (COVID‐19). Ribavirin is a broad‐spectrum antiviral with demonstrated in vitro activity against multiple viruses, including severe acute ...
Garyfallia Poulakou, Maxime Barakat, Robert J. Israel, Marcelo R. Bacci, Virazole Collaborator Group for COVID‐19 Respiratory Distress   +4 more
doaj   +1 more source